News
Thirty-five states have agreed to participate in a federal pilot program aimed at helping Medicaid patients access costly ...
Martin Mwita, 20, is the first patient in St. Louis and among the first across the country to receive a new gene therapy for ...
Alpha-synuclein misfolding as fluid biomarker for Parkinson’s disease measured with the iRS platform
A new fluid biomarker for Parkinson’s disease (PD) was developed, offering a high-accuracy biological classification, ...
“lncRNAs are versatile molecules, attractive targets, and therapeutically unexplored, and we have a revolutionary platform for reprogramming disease-driving cell-states to treat rare, common and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results